4//SEC Filing
GUSSIN ROBERT Z 4
Accession 0001069530-23-000019
CIK 0001069530other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:04 PM ET
Size
15.8 KB
Accession
0001069530-23-000019
Insider Transaction Report
Form 4
GUSSIN ROBERT Z
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-01$16.66/sh+2,142$35,686→ 10,552 total - Exercise/Conversion
Common Stock
2023-05-01$16.66/sh+3,571$59,493→ 14,123 total - Tax Payment
Common Stock
2023-05-01$23.34/sh+7,077$165,177→ 10,617 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-05-01$16.66/sh−3,571$59,493→ 0 totalExercise: $16.66From: 2017-06-14Exp: 2023-06-14→ Common Stock (3,571 underlying) - Exercise/Conversion
Common Stock
2023-05-01$19.60/sh+3,571$69,992→ 17,694 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-05-01$16.66/sh−2,142$35,686→ 0 totalExercise: $16.66From: 2017-06-14Exp: 2023-06-14→ Common Stock (2,142 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-05-01$19.60/sh−3,571$69,992→ 0 totalExercise: $19.60From: 2017-05-16Exp: 2023-05-16→ Common Stock (3,571 underlying)
Footnotes (1)
- [F1]Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction.
Documents
Issuer
CASSAVA SCIENCES INC
CIK 0001069530
Entity typeother
Related Parties
1- filerCIK 0001245263
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:04 PM ET
- Size
- 15.8 KB